“Revolutionizing Heart Care & Empowering Patients:” Sirolimus-Driven Balloon Innovation Emerges as a More Effective Alternative to Stents in Larger Arteries
San Francisco, November 2025 — In a defining chapter for global cardiovascular care, MedAlliance, the Swiss-based innovator behind the patented SELUTION Sirolimus Drug-Eluting Balloon (DEB), continues to

